State Ledger
Company profile

Matinas BioPharma Holdings, Inc. CIK 1582554

Ticker
MTNB (NYSE)
Industry
Pharmaceutical Preparations
Headquarters
Bedminster, NJ 07921
Fiscal year end
2025 (FY)
Market Data
Close
$2.72
Change
-$0.10
Change %
-3.55%
Volume
849

MTNB · trading date Oct 12, 2026 · previous close $2.82 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$10.35M
Total assets
$7.21M
Total liabilities
$2.38M
Stockholders' equity
$4.83M
Cash & equivalents
$4.00M
Operating income
-$6.96M
Operating cash flow
-$7.01M
Capital expenditures
—

Fiscal year 2025, via 10-K filed 2026-03-31. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
33.0%
Equity / assets
67.0%
CapEx / revenue
—
Operating cash flow / net income
0.68×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$10.35M $7.21M $2.38M $4.83M
2024 — -$24.25M $12.64M $5.05M $7.59M
2023 $1.10M -$22.94M $25.10M $5.86M $19.25M
2022 $3.19M -$21.00M $44.82M $8.18M $36.64M
2021 $33.0K -$23.28M $61.33M $8.83M $52.49M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-09-16
Financials filed via
Form 10-K
filed 2026-03-31

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Bedminster, NJ 07921
1545 ROUTE 206 SOUTH
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:40 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to New Jersey — Public Companies